Contact
Please use this form to send email to PR contact of this press release:
Revolo Biotherapeutics Completes Enrollment in Phase 2 Trial of ‘1104 in Allergic Disease
TO:
Please use this form to send email to PR contact of this press release:
Revolo Biotherapeutics Completes Enrollment in Phase 2 Trial of ‘1104 in Allergic Disease
TO: